½ÃÀ庸°í¼­
»óǰÄÚµå
1591858

ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå : Á¦Ç°, ÀûÀÀÁõ, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Home Infusion Services Market by Product (Infusion Pumps, Intravenous Sets, IV Cannulas), Indication (Anti-Infective, Chemotherapy, Enteral Nutrition), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 222¾ï ´Þ·¯, 2024³â¿¡´Â 242¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.77%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 426¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀçÅà ¼ö¾× ¼­ºñ½º´Â Ç×»ýÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦, È­Çпä¹ý, ¿µ¾çÁ¦, ¸é¿ª±Û·ÎºÒ¸°°ú °°Àº ¾à¹°À» ºñÀÓ»ó ȯ°æ(º¸Åë °¡Á¤)¿¡¼­ ȯÀÚÀÇ Ã¼³»¿¡ Åõ¿©ÇÏ´Â ÀÇ·á °úÁ¤À» ¸»ÇÕ´Ï´Ù. ÀÌ ¼­ºñ½º´Â ¸Å¿ì Áß¿äÇϸç, ÆíÀǼº, ÀÇ·á ºñ¿ë Àý°¨, ¸¸¼º Áúȯ¿¡ ´ëÇÑ ÀûÀÀ·Â Çâ»ó, ȯÀÚÀÇ Æí¾ÈÇÔ ¹× ¼øÀÀµµ °³¼± µîÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ÀÀ¿ë ºÐ¾ß´Â ¸¸¼º Áúȯ °ü¸®, °¨¿°, ¼ö¼ú ÈÄ È¸º¹ Ä¡·á µîÀÔ´Ï´Ù. ¼Ò¾Æ, ¼ºÀÎ, ³ëÀΠȯÀÚ µî ´Ù¾çÇÑ ¿¬·É´ëÀÇ È¯Àڵ鿡°Ô Àû¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á Áõ°¡¿Í °í·ÉÈ­ Ãß¼¼´Â ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¼ö¾× ÀåÄ¡ÀÇ ±â¼ú ¹ßÀü, ¾Ï, ´ç´¢º´ µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ÀçÅÃÄ¡·á ¼­ºñ½º ¼ö¿ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ÀÇ·áºñ »ó½Â°ú º´¿ø ÀÔ¿øÀϼö ´ÜÃàÀ» À§ÇÑ ³ë·Â °­È­´Â ÀÌ·¯ÇÑ ¼­ºñ½º äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï±¹ÀÇ ¹Ì°³Ã´ ½ÃÀå, ¿ø°Ý ÀÇ·áÀÇ ¹ßÀüÀ¸·Î ÀÎÇÑ ¸ð´ÏÅ͸µ °­È­, °³ÀÎ ¸ÂÃãÇü ÀÇ·á Æ®·»µå Áõ°¡ µîÀ¸·Î ÀÎÇØ ÀáÀçÀûÀÎ ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ÇÏÁö¸¸, ºÒÃæºÐÇÑ ÀÓ»ó Ä¡·áÀÇ À§Çè, ÀáÀçÀûÀÎ Åõ¾à ½Ç¼ö, ¼ö¾× Àåºñ¿¡ ´ëÇÑ ±ÔÁ¦Àû Àå¾Ö¹° µîÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì°³¹ß Áö¿ª¿¡¼­ÀÇ ÀÎ½Ä ºÎÁ·°ú ºÎÁ·ÇÑ ÀÇ·á ÀÎÇÁ¶ó µîÀÇ À庮µµ Å« Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ °¡Àå ÁÁÀº ºÐ¾ß·Î´Â »ç¿ëÀÚ Ä£È­ÀûÀ̰í ÈÞ´ë °¡´ÉÇÑ ¼ö¾× ÁÖÀÔ ±â±â °³¹ß, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ȯÀÚ Áö¿øÀ» À§ÇÑ AI Ȱ¿ë, °£º´ÀÎ ¼÷·Ãµµ Çâ»óÀ» À§ÇÑ ±³À° ÇÁ·Î±×·¥ °³¹ß µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. »ç¾÷ ¼ºÀå¿¡ ´ëÇÑ ÅëÂû·ÂÀº ºñ¿ë È¿À²ÀûÀÎ ÇコÄɾî¿Í ±â¼ú ÅëÇÕ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä°¡ ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ ¼º°ÝÀ» ½Ã»çÇÕ´Ï´Ù. ¿ø°Ý ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê°ú ¸®½ºÅ© ¿ÏÈ­¸¦ À§ÇÑ ±³À°¿¡ ´ëÇÑ °­Á¶´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¼ö¾× ±â¼úÀÇ Çõ½Å¿¡ ´ëÇÑ Å½±¸¿Í AI µµ±¸ÀÇ Ã¤ÅÃÀº ÀÇ·á »ê¾÷ÀÇ µðÁöÅÐ Çõ½Å°ú ¹ÐÁ¢ÇÏ°Ô ¿¬°èµÇ¾î À¯¸ÁÇÑ ¼ºÀå ¼ö´ÜÀ» Á¦°øÇÒ °ÍÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 222¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 242¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 426¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 9.77%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°ü, Á¤Çü¿Ü°ú, ´ç´¢º´, ¾Ï µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡
    • ³ëÀÎ Àα¸ Áõ°¡¿Í ÀÇ·á½Ã¼³ÀÇ Á¸Àç
    • ÀçÅÃÀÇ·á¿¡¼­ Á¤¸ÆÁÖ»ç ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ÀçÅà ¼ö¾× ¿ä¹ýÀÇ Áö¼ÓÀûÀÎ °­È­ ¹× ±â¼ú ¹ßÀü
    • ¿¬±¸ °³¹ß ÅõÀÚ °¡¼ÓÈ­
  • ½ÃÀå °úÁ¦
    • ÀçÅà ¼ö¾× ¿ä¹ý »óȯ ºÎÁ·

Portre's Five Forces: ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

"Portre's Five Forces" ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå : Á¦Ç°º°

  • ÁÖÀÔ ÆßÇÁ
    • ¿¤¶ó½ºÅä¸Ó
    • Àü±â ±â°è
    • Áß·Â
  • Á¡Àû ¼¼Æ®
  • IV ij´¼¶ó
  • ¹«¹Ù´Ã Ä¿³ØÅÍ

Á¦7Àå ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå ÀûÀÀÁõº°

  • Ç×°¨¿°
  • È­Çпä¹ý
  • °æÀ念¾ç
  • ¼öºÐ º¸±Þ ¿ä¹ý
  • ¸é¿ª±Û·ÎºÒ¸° ¿ä¹ý
  • ¿ÏÀü Á¤¸Æ ¿µ¾ç

Á¦8Àå ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå : ¿ëµµº°

  • Ç×°¨¿°
  • È­Çпä¹ý
  • ³»ºÐºñÇÐ
    • ´ç´¢º´
  • °æÀå ¿µ¾ç
  • ¼öºÐ º¸±Þ ¿ä¹ý
    • ¾Ö½½¸®Æ®
  • °æÀå ¿µ¾ç
  • Àü¹® ÀǾàǰ

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦112Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀçÅà ¼ö¾× ¼­ºñ½º ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Caesarea Medical Electronics Ltd.
  • CareFusion Corporation
  • Coram LLC.
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • KKR & Co. Inc.
  • McKesson Corporation
  • Option Care Health
  • PharMerica Corporation
  • Smiths Medical, Inc.
  • Terumo Corporation
LSH

The Home Infusion Services Market was valued at USD 22.20 billion in 2023, expected to reach USD 24.26 billion in 2024, and is projected to grow at a CAGR of 9.77%, to USD 42.64 billion by 2030.

Home infusion services refer to the medical process of administering medications such as antibiotics, antivirals, chemotherapy, nutrition, and immunoglobulin into a patient's body in a non-clinical setting, commonly their home. This service is crucial, providing benefits like convenience, reduced healthcare costs, enhanced suitability for chronic conditions, and improved patient comfort and compliance. Key applications include the management of chronic diseases, infections, and post-surgical recovery treatments. The end-use scope is vast, catering to pediatric, adult, and geriatric patients. Growing trends in personalized medicine and an aging population significantly bolster market growth. Key growth factors include technological advancements in infusion devices, increasing prevalence of chronic diseases such as cancer and diabetes, and rising demand for home healthcare services. The surge in healthcare costs and enhanced focus on reducing hospital stays further drive the adoption of these services. However, potential opportunities lie in untapped markets in emerging economies, leveraging advances in telehealth for enhanced monitoring, and the increasing trend of personalized medicine. Nevertheless, challenges such as the risk of insufficient clinical care, potential medication errors, and regulatory hurdles regarding infusion equipment could hinder market growth. Barriers such as lack of awareness and inadequate healthcare infrastructure in underdeveloped regions also pose significant limitations. The best areas for innovation include developing user-friendly, portable infusion devices, leveraging AI for real-time monitoring and patient support, and creating training programs to enhance caregiver proficiency. Business growth insights suggest a dynamic nature of the market, driven by continuous demand for cost-effective healthcare and technological integration. Strategic partnerships with telehealth providers and emphasis on training to mitigate risks could further propel market expansion. Exploring innovations in wearable infusion technology and adopting AI tools offers promising growth avenues, aligning closely with the healthcare industry's digital transformation.

KEY MARKET STATISTICS
Base Year [2023] USD 22.20 billion
Estimated Year [2024] USD 24.26 billion
Forecast Year [2030] USD 42.64 billion
CAGR (%) 9.77%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Home Infusion Services Market

The Home Infusion Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic ailments such as cardiovascular, orthopedic, diabetes, and cancer
    • Growing geriatric population and the presence of healthcare facilities
    • Rising demand for home care intravenous drug infusion therapy
  • Market Restraints
    • Limited availability of skilled professionals
  • Market Opportunities
    • Ongoing enhancements and technological advancements in home infusion therapy
    • Accelerating investments in research and development activities
  • Market Challenges
    • Dearth of reimbursement for home infusion therapy

Porter's Five Forces: A Strategic Tool for Navigating the Home Infusion Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Home Infusion Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Home Infusion Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Home Infusion Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Home Infusion Services Market

A detailed market share analysis in the Home Infusion Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Home Infusion Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Home Infusion Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Home Infusion Services Market

A strategic analysis of the Home Infusion Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Home Infusion Services Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Caesarea Medical Electronics Ltd., CareFusion Corporation, Coram LLC., Fresenius Kabi AG, ICU Medical, Inc., JMS Co. Ltd., KKR & Co. Inc., McKesson Corporation, Option Care Health, PharMerica Corporation, Smiths Medical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Home Infusion Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors. The Infusion Pumps is further studied across Elastomeric, Electromechanical, and Gravity.
  • Based on Indication, market is studied across Anti-Infective, Chemotherapy, Enteral Nutrition, Hydration Therapy, Immunoglobulin Therapy, and Total Parenteral Nutrition.
  • Based on Application, market is studied across Anti-infective, Chemotherapy, Endocrinology, Enteral Nutrition, Hydration Therapy, Parenteral Nutrition, and Specialty Pharmaceuticals. The Endocrinology is further studied across Diabetes. The Hydration Therapy is further studied across Athletes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic ailments such as cardiovascular, orthopedic, diabetes, and cancer
      • 5.1.1.2. Growing geriatric population and the presence of healthcare facilities
      • 5.1.1.3. Rising demand for home care intravenous drug infusion therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing enhancements and technological advancements in home infusion therapy
      • 5.1.3.2. Accelerating investments in research and development activities
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of reimbursement for home infusion therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Home Infusion Services Market, by Product

  • 6.1. Introduction
  • 6.2. Infusion Pumps
    • 6.2.1. Elastomeric
    • 6.2.2. Electromechanical
    • 6.2.3. Gravity
  • 6.3. Intravenous Sets
  • 6.4. IV Cannulas
  • 6.5. Needleless Connectors

7. Home Infusion Services Market, by Indication

  • 7.1. Introduction
  • 7.2. Anti-Infective
  • 7.3. Chemotherapy
  • 7.4. Enteral Nutrition
  • 7.5. Hydration Therapy
  • 7.6. Immunoglobulin Therapy
  • 7.7. Total Parenteral Nutrition

8. Home Infusion Services Market, by Application

  • 8.1. Introduction
  • 8.2. Anti-infective
  • 8.3. Chemotherapy
  • 8.4. Endocrinology
    • 8.4.1. Diabetes
  • 8.5. Enteral Nutrition
  • 8.6. Hydration Therapy
    • 8.6.1. Athletes
  • 8.7. Parenteral Nutrition
  • 8.8. Specialty Pharmaceuticals

9. Americas Home Infusion Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Home Infusion Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Home Infusion Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Baxter International Inc.
  • 3. Becton, Dickinson and Company
  • 4. Caesarea Medical Electronics Ltd.
  • 5. CareFusion Corporation
  • 6. Coram LLC.
  • 7. Fresenius Kabi AG
  • 8. ICU Medical, Inc.
  • 9. JMS Co. Ltd.
  • 10. KKR & Co. Inc.
  • 11. McKesson Corporation
  • 12. Option Care Health
  • 13. PharMerica Corporation
  • 14. Smiths Medical, Inc.
  • 15. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦